Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Key Information
Due Date: January 7, 2028
Agency: United States Department of Health and Human Services
Source: Federal
Website: View Website
Funding Categories:
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
Overview
This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, healthcare delivery, and digital health and data science, and implementation science.
Show More
Additional Info
Posted Date: November 7, 2024
Application Due Date: January 7, 2028
Estimated Award Date: Not Specified
Eligible Applicants:
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- City or township governments
- Others
- Small businesses
- Private institutions of higher education
- Special district governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- State governments
- For profit organizations other than small businesses
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- County governments
- Independent school districts
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Public and State controlled institutions of higher education
Apply with Confidence
Our partners at Syncurrent help local governments move from searching to applying. Confirm eligibility, access funding documents, and begin building a complete application in a single secure platform.
